期刊文献+

表皮生长因子受体酪氨酸激酶抑制剂AG1478对卵巢癌细胞生物活性及纤溶酶原激活物抑制物1的作用机制研究 被引量:4

Study on the mechanism of epidermal growth factor receptor tyrosine kinase inhibitor AG1478 on the biological activity of ovarian cancer cells and plasminogen activator inhibitor type 1
下载PDF
导出
摘要 目的探讨AG1478对卵巢癌细胞生物活性及纤溶酶原激活物抑制物1(PAI-1)的作用机制。方法将CaOV-3细胞分为空白组和干预组,空白组为无药物干预的CaOV-3细胞,干预组分别为干预A组(5μmol的AG1478溶液)、干预B组(10μmol的AG1478溶液)、干预C组(15μmol的AG1478溶液)和干预D组(20μmol的AG1478溶液)。分别采用四甲基偶氮唑蓝(MTT)法、流式细胞仪及Transwell小室检测细胞抑制率、凋亡率及侵袭数目,采用蛋白质印迹(Western blot)法和逆转录聚合酶链反应(RT-PCR)分别检测PAI-1、尿激酶型纤溶酶原激活剂受体(uPAR)蛋白和mRNA水平。结果不同时间点干预B组、干预C组和干预D组CaOV-3细胞抑制率均高于干预A组,干预D组CaOV-3细胞抑制率均高于干预B组,差异均有统计学意义(P﹤0.05)。干预组CaOV-3细胞凋亡率均高于空白组,细胞侵袭数目均少于空白组,干预B组、干预C组、干预D组CaOV-3细胞凋亡率均高于干预A组,细胞侵袭数目均少于干预A组,干预D组CaOV-3细胞凋亡率高于干预B组,细胞侵袭数目少于干预B组,差异均有统计学意义(P﹤0.05)。干预组CaOV-3细胞中PAI-1、uPAR蛋白和mRNA表达量均低于空白组,干预B组、干预C组及干预D组CaOV-3细胞中PAI-1、uPAR蛋白和mRNA表达量均低于干预A组,干预D组CaOV-3细胞中PAI-1、uPAR蛋白和mRNA表达量均低于干预B组,差异均有统计学意义(P﹤0.05)。结论AG1478能够有效降低卵巢癌CaOV-3细胞存活率及侵袭性,加快凋亡,作用机制可能与阻碍PAI-1和uPAR信号通路表达有关。 Objective To investigate the mechanism of AG1478 on the biological activity of ovarian cancer cells and plasminogen activator inhibitor type 1(PAI-1).Method The CaOV-3 cells were divided into blank group and intervention group.The blank group was CaOV-3 cells without drug intervention,and the intervention group was divided into intervention group A(5μmol AG1478 solution),intervention group B(10μmol AG1478 solution),intervention C group(15μmol AG1478 solution),and intervention D group(20μmol AG1478 solution).The cell inhibition rate,apoptosis rate,and the number of invasions were detected by the methyl thiazolyl terazolium(MTT)method,flow cytometer,and Transwell chamber assay.Western blot and reverse transcription-polymerase chain reaction(RT-PCR)were used to detect PAI-1,urokinase type plasminogen activator receptor(uPAR)protein and mRNA levels,respectively.Result The inhibitory rate of CaOV-3 cells in intervention group B,intervention group C,and intervention group D were higher than those in intervention group A at different time points,and the inhibitory rate of CaOV-3 cells in intervention group D was higher than that in intervention group B,and the differences were statistically significant(P<0.05).The apoptosis rate of CaOV-3 cells in the intervention groups were higher than those of the blank group,and the number of invasion cells were less than those of the blank group.The apoptosis rate of CaOV-3 cells in intervention group B,intervention group C,and the intervention group D were all higher than that of intervention group A,while the number of invasion cells were less than that of intervention group A,the rate of apoptosis of CaOV-3 cells in intervention group D was higher than that of intervention group B,the number of invasion cells was less than that of intervention group B,the differences were statistically significant(P<0.05).The expression levels of PAI-1,uPAR protein and mRNA in CaOV-3 cells in the intervention group were lower than those in the blank group,the expressions of PAI-1,uPAR protein and mRNA in CaOV-3 cells of intervention group B,intervention C,and intervention group D were lower than those of intervention group A,the expression of PAI-1,uPAR protein and mRNA in CaOV-3 cells of intervention group D was lower than the intervention group B,and the differences were statistically significant(P<0.05).Conclusion AG1478 could effectively reduce the survival rate of ovarian cancer CaOV-3 cells and inhibit their invasiveness while inducing apoptosis,the underlying mechanism may be related to blocking the expression of PAI-1 and relevant uPAR signaling pathways.
作者 丁伯勇 王玮 昝瑛 DING Boyong;WANG Wei;ZAN Ying(Department of Oncology,Shangluo Central Hospital,Shangluo 726000,Shaanxi,China;Department of Gynecology,Shangluo Central Hospital,Shangluo 726000,Shaanxi,China;Department of Oncology,the Second Affiliated Hospital of Xi’an Jiaotong University,Xi’an 721000,Shaanxi,China)
出处 《癌症进展》 2021年第10期1002-1006,1030,共6页 Oncology Progress
基金 陕西省重点研发计划项目(2019SF-042)。
关键词 AG1478 卵巢癌 凋亡 侵袭 纤溶酶原激活物抑制物1 尿激酶型纤溶酶原激活剂受体 AG1478 ovarian cancer apoptosis invasion plasminogen activator inhibitor type 1 urokinase type plasminogen activator receptor
  • 相关文献

参考文献11

二级参考文献83

  • 1黄云剑,张远宁,王沂芹,赵景宏,杨唐俊,蔡文琴.PAI-1和TIMP-1基因在肾小管间质纤维化中的表达及HGF的干预作用[J].中国病理生理杂志,2004,20(9):1542-1546. 被引量:18
  • 2董德刚,郭恩绵,张瑶,张淑兰.桂枝茯苓对宫颈癌HeLa细胞侵袭转移及MMP-2、MMP-9表达的影响[J].山东医药,2007,47(27):49-51. 被引量:6
  • 3YG, Du Q, Fang WG, et al. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells. Int J Oncol, 2008, 33:595-602.
  • 4Ren Y, Yin H, Tian R, et al. Different effects of epidermal growth factor on smooth muscle cells derived from human myometrium and from leiomyoma. Fertil Steril, 2011,96 : 1015-1020.
  • 5Johns TG, Luwor RB, Murone C, et al. Antimmor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478. Proc Natl Acad Sci U S A, 2003, 100:15871-15876.
  • 6Lee FT,Mountain AJ, Kelly MP, etal. Enhanced efficacy of radioirmlmo- therapy with 90Y-CHX-A"-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478. Clin Cancer Res, 2005, 11: 7080s-7086s.
  • 7Gialmanidis IP, Bravou V, Amanetopoulou SG, et al. Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas. Lung Cancer, 2009, 66:64-74.
  • 8Yang DK, Son CH, Lee SK, et al. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance. Hum Pathol, 2009, 40:464-470.
  • 9Francis RE, Myatt SS, Krol J, et al. FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol, 2009, 35:57-68.
  • 10Calvisi DF, Pinna F, Ladu S, et al. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut, 2009, 58:679-687.

共引文献75

同被引文献41

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部